Search for: "Johnson v. Janssen Research " Results 1 - 17 of 17
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jun 2013, 6:43 am
It is therefore insufficient: see Novartis AG v Johnson & Johnson Medical Ltd [2010] EWCA Civ 1039, [2011] ECC 10 at [77]. [read post]
23 Nov 2015, 8:00 am by Robert Kreisman
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
29 Aug 2016, 1:19 pm by Michael Grossman
Both drugs are manufactured by Janssen Pharmaceutical, a subsidiary of the parent corporation Johnson & Johnson. [read post]
22 Oct 2021, 11:36 am by Pamela Wolf
They argued that Johnson & Johnson/Janssen used cells ultimately derived from an aborted fetus to produce its vaccine, as did Moderna and Pfizer/BioNTech in researching their vaccines. [read post]
22 Oct 2021, 11:36 am by Pamela Wolf
They argued that Johnson & Johnson/Janssen used cells ultimately derived from an aborted fetus to produce its vaccine, as did Moderna and Pfizer/BioNTech in researching their vaccines. [read post]
13 May 2010, 12:27 pm by Bexis
Johnson & Johnson, 2010 WL 271423 (N.D. [read post]
5 Jul 2008, 11:05 am
interview: (IP tango) Events 7 July: PLI briefing webcast ‘Life after Quanta v LGE: What every patent lawyer needs to know’: (PLI), 7-15 July/16-18 July: 2nd Transatlantic IP summer academy, modules one and two – Alicante/Milan: (IPKat), 9 July 2008: ALI & ABA webcast ‘Quanta v LG: What you should know’: (Patent Docs), 11 July: CIPA moot to improve participants’ understanding of procedures of EPO Technical… [read post]
24 Jun 2010, 5:00 am by Bexis
Accufix Research Institute, Inc., 253 F.3d 1180 (9th Cir. [read post]
7 Mar 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: USPTO upholds one of Wisconsin Alumni Research Foundation (WARF’s) human stem cell patents (decisions are pending on two other patents): (IPKat), (Patent Prospector), (IPBiz), (IPBiz), (IPBiz), (Patent Baristas), (IPBiz), English High Court rules Qualcomm’s patents invalid in battle against Nokia: (Philip Brooks),… [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor countries better access… [read post]
5 Sep 2008, 11:01 pm
& Ors v Deisel Spa and Case C-302/08 Zino Davidoff SA v Bendesfinanzdirektion Sudost: (Class 46), EPO Boards of Appeal finds that when a fax is transmitted and an ‘OK’ is noted by the sender, this is evidence that the transmission was successful: (IPKat), Professor Hugenholtz slams European Commission for ignoring evidence on copyright extension: (Techdirt)   Germany Federal Patent Court publishes guidelines on colour trade mark Signal Yellow:… [read post]